Robert Flisiak

Effect of HCV Core Antigen and RNA Clearance during Therapy with Direct Acting Antivirals on Hepatic Stiffness Measured with Shear Wave Elastography in Patients with Chronic Viral Hepatitis C

Mariusz Łucejko, Robert Flisiak, R. Flisiak, 2018 .

Telaprevir for previously untreated chronic hepatitis C virus infection.

Geoffrey Dusheiko, Abdul J Sankoh, Tara L. Kieffer, 2011, The New England journal of medicine.

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

Gamal Esmat, Rui Tato Marinho, Mel Krajden, 2017, The lancet. Gastroenterology & hepatology.

Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

Huy Trinh, Robert Flisiak, Franck Rousseau, 2011, Gastroenterology.

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

Huy Trinh, Robert Flisiak, Franck Rousseau, 2008, The New England journal of medicine.

Sofosbuvir and ribavirin in HCV genotypes 2 and 3.

Riina Salupere, Stefan Zeuzem, Robert Flisiak, 2014, The New England journal of medicine.

Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.

Rohit Loomba, Jörg Petersen, Thomas Berg, 2016, Journal of hepatology.

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

Thomas Berg, Robert Flisiak, Philip McCloud, 2005, The New England journal of medicine.